- cafead Sep 15, 2022 at 11:02: AM
via One of the vaccines that Pfizer has pegged for a 2023 launch has hit the mark in Phase III, setting up a filing by the end of the year.
MenABCWY, as the shot is known, is a pentavalent meningococcal vaccine candidate that combines two existing Pfizer vaccines — Trumenba and Menveo — in one. By formulating them together, the company says it could simplify the vaccination schedule with one vaccine that provides the broadest serogroup coverage of any out there.
article source
MenABCWY, as the shot is known, is a pentavalent meningococcal vaccine candidate that combines two existing Pfizer vaccines — Trumenba and Menveo — in one. By formulating them together, the company says it could simplify the vaccination schedule with one vaccine that provides the broadest serogroup coverage of any out there.
article source